NASDAQ:BOLD - Audentes Therapeutics SEC Filings & 10K Form

$37.90
-0.18 (-0.47 %)
(As of 07/21/2019 11:03 AM ET)
Today's Range
$37.51
Now: $37.90
$38.49
50-Day Range
$33.75
MA: $37.42
$40.52
52-Week Range
$17.95
Now: $37.90
$42.69
Volume304,044 shs
Average Volume471,933 shs
Market Capitalization$1.68 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.7

SEC Filings

Audentes Therapeutics (NASDAQ:BOLD) SEC Filings

DateFilerForm TypeView
07/17/2019
3:26 PM
Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/17/2019
3:24 PM
Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/26/2019
3:07 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:42 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:41 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:41 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:40 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:30 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/29/2019
3:02 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/15/2019
3:42 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/07/2019
8:30 PM
Audentes Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/07/2019
3:03 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/01/2019
1:15 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/26/2019
3:30 PM
Audentes Therapeutics (Filer)
Form DEFA14A
View Filing
04/26/2019
3:30 PM
Audentes Therapeutics (Filer)
Form DEF 14A
View Filing
04/08/2019
6:11 AM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/01/2019
4:54 PM
Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/01/2019
4:53 PM
Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/27/2019
4:03 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2019
4:16 PM
Audentes Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/27/2019
3:32 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
3:31 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
4:22 PM
Audentes Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
View Filing
02/14/2019
12:51 PM
Audentes Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
View Filing
02/12/2019
8:42 AM
Audentes Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
02/08/2019
4:50 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:29 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:28 PM
Audentes Therapeutics (Issuer)
Smith Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:27 PM
Audentes Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:25 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:23 PM
Audentes Therapeutics (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:22 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:21 PM
Audentes Therapeutics (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:20 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
4:20 PM
Audentes Therapeutics (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/25/2019
6:28 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
3:46 PM
Audentes Therapeutics (Issuer)
Mosbrooker Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/27/2018
4:43 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/10/2018
3:39 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/16/2018
5:41 PM
Audentes Therapeutics (Issuer)
NEWMAN MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/16/2018
5:37 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/16/2018
5:34 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/06/2018
4:00 PM
Audentes Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
11/06/2018
3:15 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/29/2018
3:07 PM
Audentes Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G
View Filing
10/11/2018
3:24 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/11/2018
3:15 PM
Audentes Therapeutics (Filer)
Form 424B5
View Filing
10/10/2018
9:03 AM
Audentes Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
10/09/2018
3:28 PM
Audentes Therapeutics (Filer)
Form 424B5
View Filing
10/05/2018
7:05 AM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/02/2018
6:05 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/02/2018
6:04 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/02/2018
6:03 PM
Audentes Therapeutics (Issuer)
GRAY JOHN T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/26/2018
6:00 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/24/2018
5:12 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/20/2018
6:01 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/10/2018
9:02 AM
Audentes Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
08/10/2018
3:30 PM
Audentes Therapeutics (Filer)
Form 10-Q/A
View Filing
08/10/2018
3:20 PM
Audentes Therapeutics (Filer)
Form 10-K/A
View Filing
08/07/2018
5:05 AM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/06/2018
7:24 PM
Audentes Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/05/2018
5:35 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/05/2018
5:34 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/27/2018
5:52 PM
Audentes Therapeutics (Issuer)
NEWMAN MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/27/2018
5:51 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
6:11 PM
Audentes Therapeutics (Issuer)
Nagler David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:24 PM
Audentes Therapeutics (Issuer)
Smith Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:23 PM
Audentes Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:23 PM
Audentes Therapeutics (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:22 PM
Audentes Therapeutics (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:21 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:21 PM
Audentes Therapeutics (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:20 PM
Audentes Therapeutics (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:15 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/04/2018
3:48 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2018
5:13 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/16/2018
10:31 AM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
3:16 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/08/2018
7:08 AM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/08/2018
7:05 AM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/23/2018
12:36 PM
Audentes Therapeutics (Filer)
Form CT ORDER
View Filing
04/04/2018
8:01 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/02/2018
8:06 PM
Audentes Therapeutics (Issuer)
NEWMAN MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/29/2018
7:23 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/29/2018
3:52 PM
Audentes Therapeutics (Filer)
Form S-3ASR
View Filing
03/28/2018
8:12 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/28/2018
8:11 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/12/2018
5:16 PM
Audentes Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP IV LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/09/2018
4:26 PM
Audentes Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/08/2018
3:23 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/06/2018
4:53 PM
Audentes Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP IV LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
12:07 PM
Audentes Therapeutics (Subject)
Sofinnova Venture Partners IX, L.P. (Filed by)
Form SC 13G/A
View Filing
02/14/2018
7:46 AM
Audentes Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G/A
View Filing
02/13/2018
3:03 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Audentes Therapeutics (Subject)
Form SC 13G/A
View Filing
02/13/2018
2:08 PM
Audentes Therapeutics (Subject)
Versant Side Fund IV, L.P. (Filed by)
Form SC 13G/A
View Filing
02/13/2018
8:34 AM
Audentes Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
02/12/2018
8:59 AM
Audentes Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
View Filing
02/08/2018
12:56 PM
5AM VENTURES III, L.P. (Filed by)
Audentes Therapeutics (Subject)
Form SC 13G/A
View Filing
01/25/2018
3:14 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/25/2018
3:08 PM
Audentes Therapeutics (Filer)
Form 424B4
View Filing
This page was last updated on 7/21/2019 by MarketBeat.com Staff

Featured Article: Momentum Indicators

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel